Fractyl Health (GUTS) said Wednesday it priced an underwritten public offering of about 19.5 million shares and accompanying tranche A and tranche B warrants, targeting gross proceeds of $20 million.
Shares sank 48% following an increase in intraday trading volume to over 6.4 million from a daily average of about 526,000.
LifeMD's (LFMD) shares sank 45% a day after the company lowered its full-year 2025 revenue guidance.
More than 12.6 million shares traded intraday compared with a daily average of about 1.7 million.
Evolus (EOLS) reported late Tuesday a wider Q2 loss compared with a year earlier as sales grew 4% year-over-year.
Shares slumped 31%, with intraday trading volume surging to over 10 million from a daily average of about 1.1 million.
Price: 0.98, Change: -0.89, Percent Change: -47.54
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.